Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Eukaryotic elongation factor 2 (eEF2) is a highly conserved, essential protein involved in the process of protein synthesis in eukaryotic cells. It catalyzes the GTP-dependent translocation step during mRNA translation on the ribosome, specifically moving two tRNAs and mRNA after peptidyl transfer on the 80S ribosome. The function of eEF2 is tightly regulated primarily through post-translational modifications like phosphorylation and ADP-ribosylation. Aberrant expression or regulation of eEF2 has been linked with various cancers. Inactivation via bacterial toxins leads directly to disease symptoms due to loss of cellular protein production capacity.
ADP-ribosylation (Diphtheria toxin, Exotoxin A); Phosphorylation at Thr56 by eEF2K.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eukaryotic Elongation Factor 2 (eEF2).